Results 231 to 240 of about 555,062 (342)
Translocation t(1;19)(q21;q13) in acute lymphoblastic leukemia [PDF]
Christiane Werner‐Favre+3 more
openalex +1 more source
Summary Human leukocyte antigen (HLA)‐haploidentical haematopoietic cell transplantation (haplo‐HCT) is a suitable salvage strategy in children with haematological malignancies experiencing either relapse or graft failure (GF) after the first HCT.
Riccardo Masetti+20 more
wiley +1 more source
Vaccination Following Leukemia Treatment: Viral Vaccine Responses in Survivors of Acute Lymphoblastic Leukemia. [PDF]
Konte EK+4 more
europepmc +1 more source
Evidence for chemical differences in HLA-DR molecules on autologous acute lymphoblastic leukemia and B-lymphoblastoid cell lines [published erratum appears in Blood 1987 Apr;69(4):1272] [PDF]
Lynn Graf, JM Pesando
openalex +1 more source
Treatment of Invasive Fungal Disease During Therapy for Acute Lymphoblastic Leukemia. [PDF]
Alharbi I, Nassif A, Hennawi YB.
europepmc +1 more source
Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features [PDF]
SB Murphy+7 more
openalex +1 more source
Treatment and biology of pediatric acute lymphoblastic leukemia
Motohiro Kato, A. Manabe
semanticscholar +1 more source
CD123‐targeting immunotherapeutic approaches in acute myeloid leukaemia
Summary Treatment of relapsed or refractory acute myeloid leukaemia (AML) has remained a significant challenge, with limited available targeted immunotherapies. CD123, or the interleukin‐3 (IL‐3) receptor, has long been known as a potential target expressed on AML blasts, and a range of different approaches to targeting CD123 have been trialled with ...
Alexandra Dreyzin+2 more
wiley +1 more source